The sickle cell pain drug, Adakveo, was researched and created in Oklahoma City. Several entities at the Innovation District were involved in the work, including the Oklahoma Medical Research Foundation and Cytovance Biologics.
The MAPS 4 proposal includes a number of projects intended to promote community and collaboration in an area where health, energy, aerospace, technology and research companies rub elbows.
The move was originally announced in 2018 and stems from the firm’s need to accommodate business changes and additional staff for future growth.
A number of MAPS 4 proposals designed to foster community and collaboration in Oklahoma City’s Innovation District have the potential to grow Oklahoma’s economic output exponentially.
Construction on Heartland's new headquarters is nearly half-way done. The company plans to move downtown in summer 2020.
October's Chamber Forum will be about how MAPS 4 can lead to increased economic development through the innovation district.
We also discuss Hurricane Harbor and the Wahoo Racer, more things to do at the State Fair and give a rundown of the MAPS 4 projects.
One of the largest hospital expansion projects in the nation and the largest hospital expansion project in Oklahoma history, the OU Medicine patient bed tower, is coming into the skyline. Construction started in November 2017 and the $364 million, 456,000-square-foot tower is slated to be finished in 2020.
